S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Global markets are mixed as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
Biden administration agrees to provide $6.4 billion to Samsung for making computer chips in Texas
The IRS is quicker to answer the phone on this Tax Day
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Global markets are mixed as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
Biden administration agrees to provide $6.4 billion to Samsung for making computer chips in Texas
The IRS is quicker to answer the phone on this Tax Day
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Global markets are mixed as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
Biden administration agrees to provide $6.4 billion to Samsung for making computer chips in Texas
The IRS is quicker to answer the phone on this Tax Day
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Global markets are mixed as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
Biden administration agrees to provide $6.4 billion to Samsung for making computer chips in Texas
The IRS is quicker to answer the phone on this Tax Day

3 High-Yield Dividend Stocks to Buy Now

3 High-Yield Dividend Stocks to Buy Now

There’s something so satisfying about getting dividend payouts deposited into your account. Watching the payouts stack up and compound over time is one of the most rewarding aspects of investing. People tend to gravitate towards dividend stocks because they generate passive income and can signify that a company has enough financial health to return money to shareholders. In an uncertain market, buying a company that has a strong history of dividend growth helps to provide investors with the reassurance that their money is parked in the right place for the long term.

Unfortunately, some investors that are new to dividend stocks end up chasing the highest yield stocks they can find and end up getting burned. This is usually due to the fact that when a company’s dividend payout ratio gets too high to be sustainable, it will often have to cut or eliminate its dividend altogether at some point. That’s why it’s so important to do your research before buying any dividend stocks, especially when they are high-yield. The good news is that we’ve done the hard work for you and created a list of 3 high-yield dividend stocks to buy below.

AbbVie (NYSE:ABBV)

The first stock on our list is a major pharmaceutical company that currently has a dividend yield of 4.93%. Big pharma companies like this one can be a good pick for dividend investors since they have a strong line-up of best-selling drugs that generate consistent free cash flows. AbbVie is a company that fits the bill and is in a good place financially thanks to products like Humira, which is a popular drug for people with rheumatoid arthritis. It is also a company that has some nice long-term growth potential.


Investors should be impressed by the fact that AbbVie has raised its annual dividend payout for 48 consecutive years and is a dividend aristocrat. It is also a great buy due to the potential of AbbVie’s pipeline, as it has tons of new pharmaceutical products in different phases of clinical trials. In particular, Skyrizi (for plaque psoriasis) and Rinvoq (for rheumatoid arthritis) both look promising and could eventually be best sellers for Abbvie. It looks like biotech stocks aren’t being negatively impacted by the pandemic as much as many investors initially anticipated, which is another reason why AbbVie is a strong buy at this time.

IBM (NYSE:IBM)

There’s a good chance that you are already familiar with this global information technology company. It’s worth a look thanks to its 5.22% dividend yield and a strong history of generating solid free cash flows, which means that its dividend is safe for the time being. IBM is a worldwide provider of information technology products and services and its business can benefit from new trends like cloud computing and the digitalization of major companies.

This is another dividend aristocrat that might not be growing its earnings like it once was but will be a reliable dividend-payer for those investors looking for extra income. The company’s Q2 earnings weren’t amazing, but there were some positives such as a 14.7% year-over-year increase in free cash flow to $2.9 billion in Q2. It’s also nice to see a strong balance sheet when buying a high dividend yield stock, and IBM had $14.3 billion of cash on hand at the end of Q2. Although this company faces some challenges related to the pandemic, its attractive dividend yield, strong brand name, and value at these price levels make it worth a look for dividend investors.

Realty Income (NYSE:O)

There are quite a few REITs out there that are not looking like good investments at this time. With the pandemic causing so many retailers to shutter their doors, you need to be extra careful when buying companies whose cash flows are dependent on tenants paying their monthly rent. However, Realty Income is a dividend-paying REIT that is still worth a look even in an uncertain environment for commercial properties. It’s unique in that it pays monthly dividends, which means you can expect more frequent payouts than with most other stocks. With a dividend yield of 4.55%, it is absolutely worth a look for any dividend portfolio.

The reason Realty Income is a REIT that should be on your radar has to do with the properties that make up its portfolio. Realty Income owns over 6,500 properties with a large portion of that made up of dollar, convenience, and drug stores. This is good news since those types of properties will always have a strong demand for their products and services regardless of the state of the economy. Realty Income collected 91.5% of its July rent and is another company with a very strong balance sheet. If you are looking for safety and steady income from a high-yield dividend stock, consider the fact that Realty Income has paid a dividend for 602 consecutive months.

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
AbbVie (ABBV)
4.879 of 5 stars
$162.28-3.1%3.82%59.44Moderate Buy$177.43
International Business Machines (IBM)
4.1688 of 5 stars
$182.27-2.0%3.64%22.42Hold$178.08
Realty Income (O)
4.2568 of 5 stars
$52.02-0.4%5.92%41.29Hold$60.96
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Oracle Stock Skyrockets by 15%

Oracle Stock Skyrockets by 15%

The primary takeaway from the report is that demand for AI infrastructure exceeds supply, Oracle is ramping supply as quickly as it can, and business momentum is building, driving shareholder value.

Search Headlines: